-
Posted by
Two Blokes Jul 14 -
Filed in
Stock
-
7 views
INCHEON, Korea--(BUSINESS WIRE)-- #biosimilars--Samsung Bioepis Co., Ltd. today published a whitepaper titled ‘Solving the Biosimilar Void in Europe' that proposes policy recommendations to fully recognize the value of biosimilars and ensure a more sustainable market in Europe. Biosimilars have played a significant role in alleviating the financial burden on the European healthcare system, having delivered €56 billion in cumulative cost savings across Europe over the past 11 years (2013-2024).1 However, the c.
